Literature DB >> 25426971

Host-microbe interactions in the small bowel.

Julie M Davies1, Maria T Abreu.   

Abstract

PURPOSE OF REVIEW: The intestine - home to a vast microbiome - balances its immune reactivity on a knife's edge. This review will summarize recent studies examining innate immune signals that shape the microbiota, and how pathogens can usurp protective responses to their advantage. RECENT
FINDINGS: Innate signaling uses several pathways to maintain epithelial defense. Toll-like receptor signaling through myeloid differentiation factor 88 maintains segregation between bacteria and the epithelium through production of antimicrobial proteins, and inflammasome signaling mediates efficient goblet cell release of mucus containing granules. Conversely, negative regulators of Toll-like receptor signaling help maintain a healthy microbiota resistant to pathogen infection. Methods to evade immune elimination by pathogens associated with human infections and inflammatory bowel disease are described. Emerging evidence that pattern recognition receptors can differentiate between commensals and pathogens will be examined.
SUMMARY: The balance of innate signaling in the intestine is crucial to homeostasis: too little and bacteria can directly contact the epithelium, too much depletes the protective microbiota, creating a niche for pathogens. Understanding the dynamic interaction between the immune system and the microbiota in a variety of infection and inflammation models will hopefully translate to new therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25426971      PMCID: PMC4340613          DOI: 10.1097/MOG.0000000000000143

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  28 in total

Review 1.  Negative regulation of toll-like receptor-mediated immune responses.

Authors:  Foo Y Liew; Damo Xu; Elizabeth K Brint; Luke A J O'Neill
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

2.  Host defense peptide resistance contributes to colonization and maximal intestinal pathology by Crohn's disease-associated adherent-invasive Escherichia coli.

Authors:  Joseph B McPhee; Cherrie L Small; Sarah A Reid-Yu; John R Brannon; Hervé Le Moual; Brian K Coombes
Journal:  Infect Immun       Date:  2014-05-27       Impact factor: 3.441

3.  Double-stranded RNA of intestinal commensal but not pathogenic bacteria triggers production of protective interferon-β.

Authors:  Tadaomi Kawashima; Akemi Kosaka; Huimin Yan; Zijin Guo; Ryosuke Uchiyama; Ryutaro Fukui; Daisuke Kaneko; Yutaro Kumagai; Dong-Ju You; Joaquim Carreras; Satoshi Uematsu; Myoung Ho Jang; Osamu Takeuchi; Tsuneyasu Kaisho; Shizuo Akira; Kensuke Miyake; Hiroko Tsutsui; Takashi Saito; Ikuko Nishimura; Noriko M Tsuji
Journal:  Immunity       Date:  2013-06-20       Impact factor: 31.745

4.  Toll-interacting protein modulates colitis susceptibility in mice.

Authors:  Michel H Maillard; Hristina Bega; Holm H Uhlig; Nicolas Barnich; Teddy Grandjean; Mathias Chamaillard; Pierre Michetti; Dominique Velin
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 5.  Expression and regulation of antimicrobial peptides in the gastrointestinal tract.

Authors:  R N Cunliffe; Y R Mahida
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

6.  Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides.

Authors:  A L Frantz; E W Rogier; C R Weber; L Shen; D A Cohen; L A Fenton; M E C Bruno; C S Kaetzel
Journal:  Mucosal Immunol       Date:  2012-04-11       Impact factor: 7.313

7.  SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens.

Authors:  Ho Pan Sham; Emily Yi Shan Yu; Muhammet F Gulen; Ganive Bhinder; Martin Stahl; Justin M Chan; Lara Brewster; Vijay Morampudi; Deanna L Gibson; Michael R Hughes; Kelly M McNagny; Xiaoxia Li; Bruce A Vallance
Journal:  PLoS Pathog       Date:  2013-08-08       Impact factor: 6.823

Review 8.  Anti-inflammatory properties of Type I interferons.

Authors:  Alfons Billiau
Journal:  Antiviral Res       Date:  2006-04-04       Impact factor: 5.970

9.  NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion.

Authors:  Marta Wlodarska; Christoph A Thaiss; Roni Nowarski; Jorge Henao-Mejia; Jian-Ping Zhang; Eric M Brown; Gad Frankel; Maayan Levy; Meirav N Katz; William M Philbrick; Eran Elinav; B Brett Finlay; Richard A Flavell
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

10.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

View more
  6 in total

Review 1.  Intestine, immunity, and parenteral nutrition in an era of preferred enteral feeding.

Authors:  Meredith Barrett; Farokh R Demehri; Daniel H Teitelbaum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-09       Impact factor: 4.294

Review 2.  Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.

Authors:  Eleonora Distrutti; Lorenzo Monaldi; Patrizia Ricci; Stefano Fiorucci
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Oral Probiotics Alter Healthy Feline Respiratory Microbiota.

Authors:  Aida I Vientós-Plotts; Aaron C Ericsson; Hansjorg Rindt; Carol R Reinero
Journal:  Front Microbiol       Date:  2017-07-11       Impact factor: 5.640

4.  Primary cultures of mouse small intestinal epithelial cells using the dissociating enzyme type I collagenase and hyaluronidase.

Authors:  H J Ren; C L Zhang; R D Liu; N Li; X G Li; H K Xue; Y Guo; Z Q Wang; J Cui; L Ming
Journal:  Braz J Med Biol Res       Date:  2017-04-13       Impact factor: 2.590

Review 5.  Hypoxia Inducible Factor (HIF) Hydroxylases as Regulators of Intestinal Epithelial Barrier Function.

Authors:  Mario C Manresa; Cormac T Taylor
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-02-20

Review 6.  The role of goblet cells in viral pathogenesis.

Authors:  Valerie Cortez; Stacey Schultz-Cherry
Journal:  FEBS J       Date:  2021-02-09       Impact factor: 5.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.